Physician profile
Patrick J Higgins
NPI 1174754725
$801.44
in general payments reported to CMS, 2019-2025
12 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $291 · 2022: $254 · 2023: $88.03 · 2024: $57.73 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $256.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $249.40 | 2021-2025 | Pico 7, Allevyn Heel 10.5cm X 13.5cm Ctn 5, Pico 14 |
| Heron Therapeutics, INC. | $169.97 | 2021-2023 | Zynrelef |
| Si-Bone, INC. | $83.70 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $62.50 | 2021-2022 | |
| Bioventus LLC | $61.77 | 2022-2023 | Durolane |
| Vertex Pharmaceuticals Incorporated | $47.26 | 2024-2025 | |
| Medtronic, INC. | $31.24 | 2021-2023 | Aquamantys(Tm) |
| Pfizer INC. | $30.00 | 2021 | |
| Kci USA, INC. | $22.01 | 2021 | |
| Next Science LLC | $19.44 | 2023 | Xperience, Surgx, Blastx |
| Kerecis Limited | $12.08 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $12.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Higgins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.